Bio-Rad Laboratories, Inc.
BIO.B- Exchange
- NYSE
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0000012208
No open-market purchases or sales by Bio-Rad Laboratories, Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $544.9K in total; no superinvestor holds it.
Other share classesBIO
13F holders, Q4 2021
Institutional positions in Bio-Rad Laboratories, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- 0 vs. Q3 2021
- Shares held
- 109.1K
- −1.19K (−1.1%) vs. Q3 2021
- Total value
- $82.4M
- +$60.1K (+0.1%) vs. Q3 2021
- New holders
- 0
- 2 more added
- Sold out
- 0
- 2 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BIO.B on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 5 | $544.9K |
| Q1 2026 | 7 | $1.05M |
| Q4 2025 | 6 | $860.9K |
| Q3 2025 | 5 | $809.5K |
| Q2 2025 | 5 | $520.4K |
| Q1 2025 | 5 | $518.4K |
| Q4 2024 | 8 | $1.08M |
| Q3 2024 | 6 | $1.11M |
| Q2 2024 | 8 | $935.1K |
| Q1 2024 | 7 | $1.25M |
| Q4 2023 | 6 | $1.16M |
| Q3 2023 | 8 | $2.00M |
| Q2 2023 | 7 | $2.10M |
| Q1 2023 | 10 | $2.75M |
| Q4 2022 | 9 | $1.90M |
| Q3 2022 | 8 | $2.22M |
| Q2 2022 | 8 | $2.75M |
| Q1 2022 | 7 | $2.88M |
| Q4 2021 | 12 | $82.4M |
| Q3 2021 | 12 | $82.3M |
| Q2 2021 | 10 | $70.6M |
| Q1 2021 | 10 | $10.3M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Bio-Rad Laboratories, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tikvah Management LLC | 97,027 | $73.3M | 20.45% | −1,340−1.4% | Reduced |
| CSS LLC | 7,375 | $5.57M | 0.25% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 2,200 | $1.59M | 0.00% | −100−4.3% | Reduced |
| Morgan Stanley | 692 | $522.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 496 | $374.0K | 0.00% | +44+9.7% | Added |
| Gamco Investors, Inc. Et Al | 310 | $234.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 299 | $226.0K | 0.00% | +202+208.2% | Added |
| Osborne Partners Capital Management, LLC | 284 | $214.0K | 0.02% | 00.0% | Unchanged |
| Gemmer Asset Management LLC | 279 | $211.0K | 0.02% | 00.0% | Unchanged |
| Wells Fargo & Company | 56 | $42.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 51 | $39.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 38 | $29.0K | 0.00% | 00.0% | Unchanged |